World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 30 March 2015
Main ID:  NCT01985607
Date of registration: 08/11/2013
Prospective Registration: No
Primary sponsor: United Pharmaceuticals
Public title: Efficacy of a New Thickened Extensively Hydrolyzed Formula ALLAR
Scientific title: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Cow's Milk Hypersensitivity
Date of first enrolment: February 2011
Target sample size: 72
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01985607
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Belgium Greece Kuwait Lebanon Slovenia
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- term born infants

- Having a Vandenplas' score of regurgitation of at least 2

- With suspected diagnosis of CMA because of clinical history/symptoms (based on a
Cow's Milk Protein hypersensitivity (CMPH) score of 10 or more) and/or positive
Immunoglobulin E (IgE) testing, radioallergosorbent test (RAST) or skin prick test

Exclusion Criteria:

- Exclusively breast fed infants

- Fed with an extensively hydrolysed formula or amino acid formula



Age minimum: N/A
Age maximum: 6 Months
Gender: Both
Health Condition(s) or Problem(s) studied
Cow's Milk Protein Hypersensitivity
Protein Allergy
Intervention(s)
Dietary Supplement: Extensively hydrolysed formula
Dietary Supplement: new extensively hydrolysed formula
Primary Outcome(s)
Number of patient dropped out for intolerance [Time Frame: 1 month]
Vandenplas' regurgitations score [Time Frame: 1 month]
Secondary Outcome(s)
Growth (weight, height, head circumference) [Time Frame: 1 month]
Growth (weight, height, head circumference) [Time Frame: 3 months]
Growth (weight, height, head circumference) [Time Frame: 6 months]
Cow's milk protein hypersensitivity score [Time Frame: 1 month]
Number of daily regurgitations [Time Frame: 1 month]
Secondary ID(s)
UP08-ALLAR
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history